Stay updated on Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a new page build. The change does not modify study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the site interface.
    Difference
    0.1%
    Check dated 2026-06-28T08:44:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a recruitment-closed notice ('No longer looking for participants') and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a minor formatting change to the Intervention/Treatment label and an updated Revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:24:55.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a minor site update rather than a change to the study data on the page.
    Difference
    0.1%
    Check dated 2026-06-06T23:37:17.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous revision label. This reflects a minor update to the document without altering its content.
    Difference
    0.1%
    Check dated 2026-05-16T09:25:38.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T06:02:54.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.